These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 2684408)
1. [Hemofiltration and hemoperfusion performed in series for the purpose of removing beta 2 microglobulin]. Marangoni R; Civardi F; Savino R; Manfredi A; Masi F; Avanzi C; Lino S Cas Lek Cesk; 1989 Sep; 128(39):1217-20. PubMed ID: 2684408 [TBL] [Abstract][Full Text] [Related]
2. [Changes in the beta 2-microglobulin level during hemodialysis]. Nikitinskaia LP; Stetsiuk EA; Iarmolinskiĭ IS; Barinov AV; Kon'kova TA Urol Nefrol (Mosk); 1990; (5):29-31. PubMed ID: 2264202 [TBL] [Abstract][Full Text] [Related]
10. [Developing trends in the active therapy of kidney failure. Hemodialysis--hemofiltration--hemoperfusion]. Klinkmann H; Kolff WJ Z Gesamte Inn Med; 1978 Jun; 33(11):351-5. PubMed ID: 685330 [TBL] [Abstract][Full Text] [Related]
12. Preliminary report on the efficiency of combined haemodialysis-haemoperfusion treatment in chronic uraemia. Albertazzi A; Cappelli P; Di Paolo B; Evangelista M Life Support Syst; 1984; 2(4):245-51. PubMed ID: 6527556 [TBL] [Abstract][Full Text] [Related]
13. [Correlation of complement activation, cytokine liberation and beta 2 microglobulin in the use of various dialysis and hemofiltration membranes]. Falkenhagen D; Thomaneck U; Brown GS; Werner H; Klinkmann H Z Urol Nephrol; 1989 Oct; 82(10):541-50. PubMed ID: 2692346 [TBL] [Abstract][Full Text] [Related]
14. [The effect of hemoperfusion through activated charcoal on middle molecular substances in the plasma during a long-term dialysis program]. Mydlík M; Dzúrik R; Derzsiová K; Spustová V Cas Lek Cesk; 1983 Dec; 122(51):1573-6. PubMed ID: 6652672 [No Abstract] [Full Text] [Related]
15. Hemofiltration or hemodiafiltration with on-line production of substitution fluid: clinical observation of safety and effectiveness. Li X; Li M; Liu T; Li L; Duan L; Li Y; Yang G; Guo L Chin Med J (Engl); 1997 Jul; 110(7):520-5. PubMed ID: 9594209 [TBL] [Abstract][Full Text] [Related]
16. [Influence of different blood purification treatment on the serum leptin and neuropeptide Y levels in patients with chronic renal failure]. Song J; Li H; Zhang XD Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Nov; 26(11):1116-8. PubMed ID: 21322279 [TBL] [Abstract][Full Text] [Related]
17. The effect of hollow-fiber dialyzer Plivadial Altra-Flux 140 on beta-2-microglobulin removal. Kes P; Zubcić A; Ratković-Gusić I; Prsa M; Sefer S Acta Med Croatica; 1997; 51(2):105-9. PubMed ID: 9204596 [TBL] [Abstract][Full Text] [Related]
18. In vivo clearance and elimination of nine marker substances during hemofiltration with different membranes. Krämer BK; Pickert A; Hohmann C; Liebich HM; Müller GA; Hablitzel M; Risler T Int J Artif Organs; 1992 Jul; 15(7):408-12. PubMed ID: 1516991 [TBL] [Abstract][Full Text] [Related]
19. Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion. A comparison of efficiency. Weiss LG; Danielson BG; Fellström B; Wikström B Nephron; 1989; 51(3):325-9. PubMed ID: 2918944 [TBL] [Abstract][Full Text] [Related]